Your browser doesn't support javascript.
loading
Efficacy and safety of palbociclib in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with preexisting conditions: A post hoc analysis of PALOMA-2.
Gelmon, Karen; Walshe, Janice M; Mahtani, Reshma; Joy, Anil A; Karuturi, Meghan; Neven, Patrick; Lu, Dongrui Ray; Kim, Sindy; Schnell, Patrick; Bananis, Eustratios; Schwartzberg, Lee.
Affiliation
  • Gelmon K; British Columbia Cancer Agency, Vancouver, BC, Canada. Electronic address: kgelmon@bccancer.bc.ca.
  • Walshe JM; Cancer Trials Ireland, Dublin, Ireland.
  • Mahtani R; Sylvester Cancer Center, University of Miami, Deerfield Beach, FL, USA.
  • Joy AA; Cross Cancer Institute, Edmonton, AB, Canada.
  • Karuturi M; MD Anderson Cancer Center, Houston, TX, USA.
  • Neven P; Breast Centre, UZ Leuven, Leuven, Belgium.
  • Lu DR; Pfizer Inc, San Diego, CA, USA.
  • Kim S; Pfizer Inc, San Diego, CA, USA.
  • Schnell P; Pfizer Inc, New York, NY, USA.
  • Bananis E; Pfizer Inc, New York, NY, USA.
  • Schwartzberg L; West Cancer Center, Germantown, TN, USA.
Breast ; 59: 321-326, 2021 Oct.
Article in En | MEDLINE | ID: mdl-34388698
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Estrogen Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Breast Journal subject: ENDOCRINOLOGIA / NEOPLASIAS Year: 2021 Document type: Article